These data demonstrate that JAK2/IDH-mutant MPN is initiated and propagated in LT-HSCs, in contrast to IDH- and Tet2-mutant AML models, in which leukemic stem cell capacity is maintained in the MPP cell population. The gene discussed is IDH2; the disease is myeloproliferative neoplasm.